Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan

被引:31
|
作者
Iseki, Kunitoshi [1 ]
Nakai, Shigeru [1 ]
Shinzato, Takahiro [1 ]
Morita, Osamu [1 ]
Shinoda, Toshio [1 ]
Kikuchi, Kenjiro [1 ]
Wada, Atsushi [1 ]
Kimata, Naoki [1 ]
Akiba, Takashi [1 ]
机构
[1] Japanese Soc Dialysis Therapy, Patient Registrat Comm, Tokyo, Japan
关键词
cardiovascular disease; chronic dialysis; hypertension; survival;
D O I
10.1111/j.1744-9987.2007.00479.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is common in chronic hemodialysis (HD) patients. However, its prevalence and determinants have not been studied in a large HD population. We analyzed the database of the Japanese Society for Dialysis Therapy (JSDT) registry, which conducts an annual survey of chronic dialysis patients throughout Japan. We compiled those who were on HD three-times per week and aged 20 years and over at the end of 2000 (JSDT standard analysis file 001). Hypertension was defined as predialysis systolic blood pressure (SBP) >= 140 mm Hg or predialysis diastolic blood pressure (DBP) >= 90 mm Hg. Adjusted odds ratios (95% confidence interval) for the determinants of hypertension were calculated by the multivariate logistic regression analysis. A total of 65 393 people (men, 60.2%; mean age +/- SD, 60.9 +/- 12.8 years; and mean duration of HD +/- SD, 95.3 +/- 74.0 months) were studied. Mean +/- SD levels of SBP and DBP were 154.9 +/- 23.8 mm Hg and 80.5 +/- 13.7 mm Hg before the HD session. Hypertension was noted in 77.5% of patients. Prescription of antihypertensive drugs and erythropoietin was made to 60.7% and 82.0% of patients, respectively. Both SBP and DBP were higher in those who were prescribed antihypertensive drugs (mean, 160.4/81.9 mm Hg), than those without drugs (mean, 146.9/78.5 mm Hg) (in both cases P < 0.0001). Hypertension was positively associated with men (adjusted odds ratio (OR), 1.258; 95% confidence interval (CI), 1.188-1.333; P < 0.0001), age (OR, 1.004; CI, 1.001-1.006; P < 0.01), duration of HD (OR, 0.769; CI, 0.728-0.812; P < 0.0001), serum albumin (OR, 1.369; CI, 1.286-1.458; P < 0.0001), and change in body weight by dialysis session (Delta BW) (OR, 1.176; CI, 1.159-1.194; P < 0.0001), and was negatively associated with Kt/V (OR, 0.600; CI, 0.543-0.664; P < 0.0001), and hematocrit (OR, 0.964; CI, 0.959-0.970; P < 0.0001). The distribution of Delta BW was normal in shape and in about 22% of patients the range was from 4.0% to 4.9%. There was a significant positive relationship between the prevalence of hypertension and Delta BW (R-2 = 0.8549). The higher the Delta BW, the more the prescription rate of antihypertensive drugs increased (R-2 = 0.9102). Results showed that the prevalence of hypertension was significantly associated with volume excess and serum levels of albumin, calcium, and phosphorous in chronic HD patients. Despite the high prescription rate of antihypertensive drugs, control of blood pressure remains unsatisfactory.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [1] Prevalence of hypertension among patients on chronic hemodialysis
    Vukusich, A
    Fierro, A
    Morales, J
    Fantuzzi, A
    Vukusich, C
    Mañalich, J
    Zehnder, C
    REVISTA MEDICA DE CHILE, 2002, 130 (06) : 610 - 615
  • [2] Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients
    Agarwal, Rajiv
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (10) : 3908 - 3914
  • [3] Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States
    Agarwal, R
    Nissenson, AR
    Batlle, D
    Coyne, DW
    Trout, JR
    Warnock, DG
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 (04): : 291 - 297
  • [4] PREVALENCE AND MANAGEMENT OF HYPERTENSION IN HEMODIALYSIS PATIENTS
    AlSahow, Ali
    Alyousef, Anas
    Alhelal, Bassam
    AlRajab, Heba
    Bahbahani, Yousif
    Nawar, Hani
    Elsayed, Mostafa Mohammed
    Ibrahim, Mohammed
    Elabbadi, Mohamed
    Kamel, Vivian F.
    Abdallah, Emad
    Kumar, Rajeev
    AlSahu, Ebrahim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 470 - U843
  • [5] PREVALENCE OF MASKED HYPERTENSION IN HEMODIALYSIS PATIENTS
    Borodulina, Ekaterina
    Shutov, Alexander M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35
  • [6] Prevalence, treatment and control of hypertension in chronic hemodialysis patients in the United States.
    Agarwal, R
    Nissenson, AR
    Batlle, D
    Coyne, DW
    Trout, JR
    Warnock, DG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 212A - 212A
  • [7] Prevalence and determinants of interatrial block in hemodialysis patients
    Marano, Marco
    D'Amato, Anna
    Tomasino, Giuseppe
    Izzo, Francesco
    Capasso, Marco
    Auletta, Eugenio
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (03) : 571 - 572
  • [8] Prevalence and determinants of erectile dysfunction in hemodialysis patients
    Rosas, SE
    Joffe, M
    Franklin, E
    Strom, BL
    Kotzker, W
    Brensinger, C
    Grossman, E
    Glasser, D
    Feldman, HI
    KIDNEY INTERNATIONAL, 2001, 59 (06) : 2259 - 2266
  • [9] Prevalence and determinants of interatrial block in hemodialysis patients
    Marco Marano
    Anna D’Amato
    Giuseppe Tomasino
    Francesco Izzo
    Marco Capasso
    Eugenio Auletta
    International Urology and Nephrology, 2015, 47 : 571 - 572
  • [10] Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants
    Zhao, Xinju
    Zhu, Li
    Jin, Wenying
    Yang, Bing
    Wang, Yan
    Ni, Mengfan
    Zhao, Yuchao
    Gan, Liangying
    Zuo, Li
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)